Studies of the mode of action of antitumour triazenes and triazines—II. Investigation of the selective toxicity of 1-aryl-3,3-dimethyltriazenes

This publication has 12 references indexed in Scilit:

• Antitumour activity, biomimetic oxidation and metabolism of heteroalicyclic triazenes
  Biochemical Pharmacology, 1979
• Microsomal mediated metabolism of dialkylaryltriazenes
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1979
• α-hydroxylated derivatives of antitumour dimethyltriazenes
  Tetrahedron Letters, 1978
• Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 2. On the role of correlation analysis in decision making in drug modification. Toxicity quantitative structure-activity relationships of 1-(X-phenyl)-3,3-dialkyltriazenes in mice
  Journal of Medicinal Chemistry, 1978
• Monoalkyltriazenes
  Chemical Society Reviews, 1978
• Tumour inhibitory triazenes: Structural requirements for an active metabolite
  Biochemical Pharmacology, 1976
• Unterschiedliche carcinogene Wirkungen von 1-Phenyl- und 1-(Pyridyl-3)-3,3-diäthyl-triazen an BD-Ratten nach Gabe einer Einzeldosis am 1., 10. oder 30. Lebenstag
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1976
• Studies on the mechanism of action of the tumour inhibitory triazenes
  Biochemical Pharmacology, 1973
• 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388)—A new antitumor agent with activity against malignant melanoma
  Published by Elsevier ,1972
• Mechanism of carcinogenesis with 1-Aryl-3,3-dialkyltriazenes. Enzymatic dealkylation by rat liver microsomal fraction in vitro
  Biochemical Pharmacology, 1969